20
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Successful Treatment of Chronic Disseminated Candidiasis with Fluconazole and a Granulocyte?Macrophage Colony-stimulating Factor Combination

, &
Pages 784-786 | Published online: 08 Jul 2009

  • Bodey GP, DeJongh D, Isassi A, Freireich EJ. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia. Cancer 1969; 26: 417–20.
  • Bodey GP, Bueltmann B, Duguid W. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Inf Dis 1992; 11: 99–109.
  • Anttila VJ, Elonen E, Nordling S. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997; 24: 375–80.
  • Edwards JE. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone, 1995: 2299.
  • Heiken JP. Liver. In: Lee JKT, Sagel SS, Stanley RJ, Heiken JP, eds. Computed body tomography with MRI correlation, 3rd edn. Philadelphia, PA: Lippincott-Raven, 1998: 744.
  • Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 1991; 91: 137–41.
  • Flannery MT, Simmons DB, Saba H, Altus P, Wallach PM, Adelman HM. Fluconazole in the treatment of hepatosplenic candidiasis. Arch Intern Med 1992; 152: 406–8.
  • Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, et al. Management of invasive candidial infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis 1996; 23: 964–72.
  • Anaissie A, Bodey G, Kantarjian H. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior Amphotericin B therapy. Am J Med 1991; 91: 142–50.
  • Verweij PE, Donelly JP, Kullberg BJ, Meis JF, De Pauw BE. Amphotericin B versus Amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. Infection 1994; 22: 81–5.
  • Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl 2): S18–22.
  • Hughes WT, Armstrong D, Bodey GP. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551–73.
  • Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Inf Dis 1993; 17: 705–7.
  • Poynton CH, Barnes RA, Rees J. Interferon g and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clin Infect Dis 1998; 26: 239–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.